TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88517655

Filing Date: 07/16/2019

To the Commissioner for Trademarks:

MARK: KINDLIA (Standard Characters, see mark)
The literal element of the mark consists of KINDLIA.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Amgen Inc., a corporation of Delaware, having an address of
      Trademark Operations - MS-28-5A
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States
      805-447-2688(phone)
      tmops@amgen.com (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations; pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders; pharmaceuticals for stimulating the growth of platelets and platelet precursor cells; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of bone disease; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


For informational purposes only, applicant's website address is: www.amgen.com

The applicant's current Attorney Information:
      Timothy J. Gaul and Elsa D. Lemoine, Richard V. Person and Stuart L. Watt of Amgen Inc.
      Trademark Operations - MS-28-5A
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States
      805-447-2688(phone)
      tmops@amgen.com (authorized)
The attorney docket/reference number is TM-1441-US-2.

The applicant's current Correspondence Information:

Timothy J. Gaul

Amgen Inc.

Trademark Operations - MS-28-5A       One Amgen Center Drive

Thousand Oaks, California 91320-1799

805-447-2688(phone)

tmops@amgen.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Timothy J. Gaul/   Date: 07/16/2019
Signatory's Name: Timothy J. Gaul
Signatory's Position: Attorney of Record, California bar member
Payment Sale Number: 88517655
Payment Accounting Date: 07/17/2019

Serial Number: 88517655
Internet Transmission Date: Tue Jul 16 19:09:54 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20190716190954
246453-88517655-620dacf9ee40a5e2b5f7333c
8c5c30e1a01762def77e86db72862827437d2218
24-DA-7736-20190716171916544257